Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Our project intends to study the 6-month efficacy of a pharmacist-led group intervention program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure. We are proposing a pilot randomized controlled study to test the efficacy and feasibility of this approach.

Inclusion Criteria:

• type 2 diabetes mellitus,
• >18 years old,
• with a documented HbA1c more than 7.0%,
• an LDL cholesterol >100 mg/dl AND a blood pressure >130/80 mm Hg documented at least once in the medical records within the last 6 months, and
• willing to comply with the study interventions will be eligible for the study.

Exclusion Criteria:

• pregnancy,
• unable to attend the group sessions,
• disease conditions such as psychiatric instability (acutely suicidal, psychotic) or organic brain injury that preclude them from performing diabetes self-care,
• enrolled in the Providence VAMC's Telehealth program